Skip to main content

Quanex Building Products CORP

For the period ended Apr 30, 2025. Filed Jun 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Apr 30, 2025 · Filed Jun 6, 2025

NX$21.17-3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows – Six

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Six Months Ended
April 30,
20252024
(In thousands)
Operating activities:
Net income$5,630$21,626
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization43,93222,046
Stock-based compensation1,8251,365
Deferred income tax1,250(155)
Other, net7,243162
Changes in assets and liabilities:
Decrease in accounts receivable5,32210,832
Increase in inventory(1,333)(3,008)
Increase in other current assets(7,828)(1,124)
Decrease in accounts payable(14,771)(12,619)
Decrease in accrued liabilities(14,048)(4,602)
(Decrease) increase in income taxes payable(5,471)1,856
(Decrease) increase in other long-term liabilities(6,268)9
Other, net504557
Cash provided by operating activities15,98736,945
Investing activities:
Capital expenditures(26,544)(17,183)
Proceeds from disposition of capital assets37693
Cash used for investing activities(26,168)(17,090)
Financing activities:
Borrowings under credit facilities125,000—
Repayments of credit facility borrowings(117,500)(15,000)
Repayments of other long-term debt(1,888)(954)
Common stock dividends paid(7,552)(5,294)
Issuance of common stock214554
Payroll tax paid to settle shares forfeited upon vesting of stock(1,400)(1,193)
Purchase of treasury stock(27,194)—
Cash used for financing activities(30,320)(21,887)
Effect of exchange rate changes on cash, cash equivalents and restricted cash2,303(293)
Decrease in cash, cash equivalents and restricted cash(38,198)(2,325)
Cash, cash equivalents and restricted cash at beginning of period102,99558,474
Cash, cash equivalents and restricted cash at end of period$64,797$56,149
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.